Company profile
Proteomedix AG
next generation blood test for prostate cancer
- Industry
- Biotechnology Research
- Employees
- 4
- Headquarters
- Schlieren
- Founded
- 2010
- Office locations
- 1
Proteomedix AG company summary
Proteomedix AG is a company in the Biotechnology Research industry, headquartered in Schlieren, founded in 2010. On LinkedIn the company has around 4 employees.
What technology does Proteomedix AG use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Proteomedix AG
Proteomedix enables personalized medicine by developing non-invasive diagnostic tests to detect and assess the prognosis of cancer, as well as to match patients with safer and more effective therapies. The first product is a blood-based test for the early diagnosis of prostate cancer. The main benefit of this test is a significantly higher accuracy compared to today’s clinical standard (blood-based PSA test). This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
Where is Proteomedix AG located?
Proteomedix AG lists 1 location.
Compare companies similar to Proteomedix AG
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Proteomedix AG proteomedix.com | Biotechnology Research | 4 | 2010 | Schlieren |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Proteomedix AG
What does Proteomedix AG do?
Proteomedix enables personalized medicine by developing non-invasive diagnostic tests to detect and assess the prognosis of cancer, as well as to match patients with safer and more effective therapies. The first product is a blood-based test for the early diagnosis of prostate cancer. The main benefit of this test is a significantly higher accuracy compared to today’s clinical standard (blood-based PSA test). This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
How many employees does Proteomedix AG have?
Proteomedix AG has around 4 employees on LinkedIn.
Where is Proteomedix AG headquartered?
Proteomedix AG is headquartered in Schlieren.
When was Proteomedix AG founded?
Proteomedix AG was founded in 2010.
Build a lead list from companies like Proteomedix AG
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.